Real ChatGPT answer · index seedhax0NWpsIT0completeHealth and wellness · women's healthinformational
What are the long-term benefits and cardiovascular risks associated with starting hormone replacement therapy early in the perimenopausal transition?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
What are the long-term benefits and cardiovascular risks associated with starting hormone replacement therapy early in the perimenopausal transition?
3 real searches · 1 real-search pass
menopausal hormone therapy early perimenopause cardiovascular risks timing hypothesis guideline 2025 NAMS AHAGoogle ↗
OBSERVED
2022 North American Menopause Society hormone therapy position statement cardiovascular prevention age 60 10 years menopauseGoogle ↗
OBSERVED
ACOG hormone therapy cardiovascular disease prevention menopause transdermal estrogen venous thromboembolismGoogle ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 3 queries…
Searches and sources
ChatGPT3 real searches · gpt-6
menopausal hormone therapy early perimenopause cardiovascular risks timing hypothesis guideline 2025 NAMS AHA Google ↗
2022 North American Menopause Society hormone therapy position statement cardiovascular prevention age 60 10 years menopause Google ↗
ACOG hormone therapy cardiovascular disease prevention menopause transdermal estrogen venous thromboembolism Google ↗
- NAMS 2022 Hormone Therapy Position Statement · menopause.org.au
- The Menopause Years · acog.org
- The 2022 hormone therapy position statement of The North American Menopause Society · pubmed.ncbi.nlm.nih.gov
- ACOG Clinical Practice Guideline: Management of... : Obstetrics & Gynecology · doi.org
- Menopause: The Journal of The North American Menopause Society · depts.washington.edu
- Hormone Therapy for Menopause · acog.org
Queries
3 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
menopausal hormone therapy early perimenopause cardiovascular risks timing hypothesis guideline 2025 NAMS AHA OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
2022 North American Menopause Society hormone therapy position statement cardiovascular prevention age 60 10 years menopause OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
ACOG hormone therapy cardiovascular disease prevention menopause transdermal estrogen venous thromboembolism OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |